IWS
ALZN icon

Insight Wealth Strategies’s Alzamend Neuro ALZN Stock Holding History

Insight Wealth Strategies’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$2.37K – 154
2023
Q3 		$2.37K Hold
7
– – ﹤0.01% 143
2023
Q2 		$5.1K Hold
7
– – ﹤0.01% 136
2023
Q1 		$4.25K Hold
7
– – ﹤0.01% 136
2022
Q4 		$5.65K Hold
7
– – ﹤0.01% 136
2022
Q3 		$9K Hold
7
– – ﹤0.01% 142
2022
Q2 		$9K Buy
+7
New +$9.07K ﹤0.01% 142
2022
Q1 		– Sell
-7
Closed -$19K – 155
2021
Q4 		$19K Buy
+7
New +$21.7K ﹤0.01% 152

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Insight Wealth Strategies's ALZN Position: Q4 2023 in Review

Insight Wealth Strategies sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 7 shares — an estimated $2.37K sold.

Insight Wealth Strategies first reported a position in ALZN in Q4 2021 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Insight Wealth Strategies reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Insight Wealth Strategies sold 7 Alzamend Neuro shares in Q4 2023, an estimated $2.37K.
  • Insight Wealth Strategies first reported a position in Alzamend Neuro in Q4 2021 and held it in 7 quarters.
  • Insight Wealth Strategies's Alzamend Neuro position peaked at $19K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Insight Wealth Strategies's 13F filing for Q4 2023, filed 12 Jan 2024.